Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China
1. 系统已在2025-08-01 15:48:25对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1007/s40258-025-00971-y
文献链接: https://link.springer.com/10.1007/s40258-025-00971-y
其他信息:
出版社: Springer Science and Business Media LLC
作者: Pengpeng Wang; Le Liang; Yamei Li
全文下载地址: https://link.springer.com/content/pdf/10.1007/s40258-025-00971-y.pdf